1. Home
  2. UNTY vs EOLS Comparison

UNTY vs EOLS Comparison

Compare UNTY & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNTY
  • EOLS
  • Stock Information
  • Founded
  • UNTY 1991
  • EOLS 2012
  • Country
  • UNTY United States
  • EOLS United States
  • Employees
  • UNTY N/A
  • EOLS N/A
  • Industry
  • UNTY Major Banks
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • UNTY Finance
  • EOLS Health Care
  • Exchange
  • UNTY Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • UNTY 458.0M
  • EOLS 493.5M
  • IPO Year
  • UNTY 1997
  • EOLS 2018
  • Fundamental
  • Price
  • UNTY $51.28
  • EOLS $6.52
  • Analyst Decision
  • UNTY Buy
  • EOLS Strong Buy
  • Analyst Count
  • UNTY 3
  • EOLS 5
  • Target Price
  • UNTY $56.00
  • EOLS $21.25
  • AVG Volume (30 Days)
  • UNTY 26.5K
  • EOLS 898.1K
  • Earning Date
  • UNTY 10-10-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • UNTY 1.07%
  • EOLS N/A
  • EPS Growth
  • UNTY 30.37
  • EOLS N/A
  • EPS
  • UNTY 4.94
  • EOLS N/A
  • Revenue
  • UNTY $116,265,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • UNTY $23.79
  • EOLS $14.01
  • Revenue Next Year
  • UNTY $9.20
  • EOLS $29.46
  • P/E Ratio
  • UNTY $10.55
  • EOLS N/A
  • Revenue Growth
  • UNTY 17.14
  • EOLS 17.15
  • 52 Week Low
  • UNTY $32.23
  • EOLS $5.71
  • 52 Week High
  • UNTY $54.64
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • UNTY 51.73
  • EOLS 48.35
  • Support Level
  • UNTY N/A
  • EOLS N/A
  • Resistance Level
  • UNTY $53.12
  • EOLS $7.58
  • Average True Range (ATR)
  • UNTY 0.94
  • EOLS 0.26
  • MACD
  • UNTY -2.04
  • EOLS -0.28
  • Stochastic Oscillator
  • UNTY 95.04
  • EOLS 84.18

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: